Work

Proteogenomics offers a novel avenue in neoantigen identification for cancer immunotherapy

Year: 2024

Type: review

Source: International Immunopharmacology

DOI: 10.1016/j.intimp.2024.113147

Authors: Yuqing Ren, Yi Yue, Xinyang Li, Siyuan Weng, Hui Xu, Long Liu, Quan Cheng, Peng Luo, Tengfei Zhang, Zaoqu Liu, Xinwei Han

Institutions: First Affiliated Hospital of Zhengzhou University, Central South University, Xiangya Hospital Central South University, Zhujiang Hospital, Southern Medical University, Chinese Academy of Medical Sciences & Peking Union Medical College, Institute of Basic Medical Sciences of the Chinese Academy of Medical Sciences

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Natural Science Foundation of Henan Province, Major Science and Technology Project of Hainan Province

Awards: G2379133573, G3350378164

OpenAlex ID: W4402482829

FWCI: 0.839

Cites: 148

Cited by: 17

Related to: 10